1. Home
  2. PRTA vs RBCAA Comparison

PRTA vs RBCAA Comparison

Compare PRTA & RBCAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • RBCAA
  • Stock Information
  • Founded
  • PRTA 2012
  • RBCAA 1974
  • Country
  • PRTA Ireland
  • RBCAA United States
  • Employees
  • PRTA N/A
  • RBCAA N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • RBCAA Major Banks
  • Sector
  • PRTA Health Care
  • RBCAA Finance
  • Exchange
  • PRTA Nasdaq
  • RBCAA Nasdaq
  • Market Cap
  • PRTA 1.2B
  • RBCAA 1.1B
  • IPO Year
  • PRTA N/A
  • RBCAA 1998
  • Fundamental
  • Price
  • PRTA $21.89
  • RBCAA $65.85
  • Analyst Decision
  • PRTA Buy
  • RBCAA
  • Analyst Count
  • PRTA 7
  • RBCAA 0
  • Target Price
  • PRTA $58.83
  • RBCAA N/A
  • AVG Volume (30 Days)
  • PRTA 255.3K
  • RBCAA 13.5K
  • Earning Date
  • PRTA 10-31-2024
  • RBCAA 11-01-2024
  • Dividend Yield
  • PRTA N/A
  • RBCAA 2.52%
  • EPS Growth
  • PRTA N/A
  • RBCAA 12.30
  • EPS
  • PRTA N/A
  • RBCAA 4.92
  • Revenue
  • PRTA $217,246,000.00
  • RBCAA $317,422,000.00
  • Revenue This Year
  • PRTA $59.66
  • RBCAA N/A
  • Revenue Next Year
  • PRTA N/A
  • RBCAA $2.56
  • P/E Ratio
  • PRTA N/A
  • RBCAA $13.14
  • Revenue Growth
  • PRTA 276.98
  • RBCAA 3.94
  • 52 Week Low
  • PRTA $18.69
  • RBCAA $42.42
  • 52 Week High
  • PRTA $55.89
  • RBCAA $69.00
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 58.55
  • RBCAA 66.28
  • Support Level
  • PRTA $20.15
  • RBCAA $60.84
  • Resistance Level
  • PRTA $22.83
  • RBCAA $62.74
  • Average True Range (ATR)
  • PRTA 0.82
  • RBCAA 1.34
  • MACD
  • PRTA 0.13
  • RBCAA 0.21
  • Stochastic Oscillator
  • PRTA 82.66
  • RBCAA 100.00

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through six reportable segments. It has traditional banking which generates the majority of revenue, warehouse, mortgage banking, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

Share on Social Networks: